Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

This post hoc analysis showed a trend towards an increase in the average number of minutes on days of CPAP use with SensAwake in the initial four weeks on their first treatment with SensAwake ON ( n = 18) compared to SensAwake OFF ( n = 12), which did not reach statistical significance (SensAwake ON 322.89 ± 26.46 versus SensAwake OFF 282.25 ± 30.58).
Comparison of the phenotype of the Adamts5 -/- -J mice of the present study with that of the Adamts5 -/- -P mice reveals some similarities supporting specificity of the phenotype, but also some quantitative and qualitative differences: (i) with respect to WAT mass: in Adamts5 -/- -J mice lower sWAT and GON fat mass was found, which was significant after 2 weeks of cold exposure, but only showed a trend in the DIO model; (ii) with respect to BAT mass: in Adamts5 -/- -J mice no significant difference with WT mice was observed after 2 weeks of cold exposure nor in the DIO model; (iii) with respect to browning of WAT: in Adamts5 -/- -J mice higher expression of UCP-1 mRNA and protein was found after 2 weeks of cold exposure (mRNA: 1.5- to 2-fold as compared to 5-fold for Adamts5 -/- -P mice).
In a study of therapeutic effects of ipilimumab (monoclonal antibody targeting CTLA-4), an increased secretion of IL-1β, IL-2, IL-4, IL-5, IL-7, IL-8, IL-10, IL-13, IL-17, Granulocyte-colony stimulating factor (G-CSF), Granulocyte-macrophage colony-stimulating factor (GM-CSF), HGF, IFNγ, Monocyte chemoattractant protein 1 (MCP-1, CCL2) and VEGF from peripheral blood mononuclear cells (PBMCs) showed a trend towards better recurrence free survival in melanoma [ 69 ].
Analysis of the correlation between HbA1c level and blood glucose fluctuations in drug‐naïve Japanese patients with type 2 diabetes showed a trend towards larger swings in blood glucose levels with high HbA1c levels. 8 Diabetes patients seen in clinical practice represent a wide range of patients and include drug‐naïve patients.
However, in patients with T2DM, those treated with volixibat showed a trend towards increased levels of serum HDL-C, decreased levels of serum triglycerides and reductions in fasting glucose levels, suggesting improvements in both lipid and glucose homeostasis.